睡眠呼吸中止症治疗设备市场规模、占有率、成长及全球产业分析：按类型、应用和地区划分的洞察，2026-2034 年

睡眠呼吸中止症治疗设备市场成长驱动因素

由于睡眠呼吸障碍盛行率的上升以及人们对早期诊断和治疗意识的提高，全球睡眠呼吸中止症治疗设备市场正经历显着增长。睡眠呼吸中止症是一种严重的睡眠障碍，其特征是睡眠期间呼吸反覆中断，导致大脑和其他器官的氧气供应减少。这种疾病在老年人和患有肥胖、糖尿病、高血压和心血管疾病等合併症的人中更为常见。根据 Fortune Business Insights 的一项研究，2025 年全球睡眠呼吸中止症治疗设备市场价值为 103 亿美元。预计该市场将从 2026 年的 110 亿美元成长到 2034 年的 228.7 亿美元，预测期内复合年增长率 (CAGR) 为 9.59%。

到 2025 年，北美将主导全球市场，占 49.55% 的市场。这主要归功于阻塞性睡眠呼吸中止症 (OSA) 的高发病率、有利的报销政策以及对技术先进的睡眠呼吸中止症治疗设备的广泛应用。

市场驱动因素

睡眠呼吸中止症治疗设备市场的主要成长驱动因素是全球阻塞性睡眠呼吸中止症 (OSA) 盛行率的不断上升。根据美国国家生物技术资讯中心 (NCBI) 发布的数据，全球约有 9.36 亿人患有轻度至重度阻塞性睡眠呼吸中止症 (OSA)，其中 4.25 亿人患有中度至重度 OSA。久坐的生活方式、肥胖、睡眠模式不良和压力增加是导致疾病发生率上升的主要因素。

此外，人口老化加剧和慢性病负担加重也推动了 OSA 诊断和治疗率的提高。美国国家睡眠基金会等机构所进行的提高公众意识的活动和宣传也促进了睡眠呼吸中止症早期诊断和治疗设备的普及。新冠疫情加剧了与压力相关的睡眠障碍，也推动了疫情期间及之后对诊断和治疗设备的需求成长。

市场趋势

影响市场的关键趋势是技术先进、人性化的设备的日益普及。口腔矫正器，例如下颚前移矫正器 (MAD)，因其舒适性、便携性和非侵入性而越来越受欢迎。 2024年2月，美国FDA批准了一种新型下颚復位装置AIO BREATHE，反映了口腔内睡眠呼吸中止症治疗方案领域技术创新的不断进步。

另一个重要趋势是便携式、经济实惠的诊断设备（例如活动记录器和家庭睡眠测试工具）的使用日益增多。这些设备因其价格实惠且适合家庭诊断而备受关注，从而推动了睡眠呼吸中止症管理模式转向分散式。

市场限制因子

儘管市场成长前景强劲，但睡眠呼吸中止症治疗设备的高昂成本仍是市场面临的挑战。持续性呼吸道正压通气（CPAP）设备广泛用于治疗阻塞性睡眠呼吸中止症（OSA），但价格昂贵，在美国通常售价在600至800美元之间，给没有医疗保险的患者带来了沉重的负担。发展中国家有限的保险覆盖范围和高昂的自付费用进一步限制了设备的普及，阻碍了市场成长。

市场区隔分析

依设备类型划分，市场分为治疗设备和诊断设备。预计到2026年，治疗设备细分市场将以63.36%的市场占有率占主导地位，这主要得益于治疗率的提高以及CPAP设备、口腔设备及面罩的广泛应用。诊断设备也持续成长，这主要归功于未确诊患者的数量以及人们对睡眠障碍诊断意识的提高。

依最终使用者划分，市场分为家庭照护及其他场所及睡眠实验室诊所。预计到2026年，家庭护理及其他场所细分市场将以53.83%的市场占有率占主导地位，这主要得益于人们对家庭治疗的偏好日益增强以及便携式诊断设备的出现。睡眠实验室诊所预计也将稳定成长，这主要得益于患者数量的增加以及熟练睡眠技师的普及。

区域洞察

北美将引领市场，预计到2025年市场规模将达到51.1亿美元，其中美国市场预计到2026年将达到51亿美元。

由于睡眠呼吸中止症的盛行率和认知度不断提高，亚太地区预计将实现最高的复合年增长率。到2026年，日本市场预计将达到4.7亿美元，中国市场预计将达到6.2亿美元，印度市场预计将达到1.9亿美元。

欧洲市场预计将稳定成长，预计到2026年，英国市场将达到4.7亿美元，德国市场将达到7.3亿美元，主要得益于老年族群较高的发生率。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

• 市场驱动因素
• 市场限制因素
• 市场机遇

第四章：关键考虑因素

• 主要国家及地区睡眠呼吸中止症盛行率（2025 年）
• 睡眠呼吸中止症治疗设备的技术进步
• 产业主要发展动态－併购与合作
• 新冠疫情对市场的影响

第五章 全球睡眠呼吸中止症治疗设备市场分析、洞察与预测 （2021-2034）

• 市场分析、洞察与预测 - 按设备类型划分
  • 治疗设备
    • 正压通气设备
    • 面罩及配件
    • 其他
  • 诊断设备
    • 多导睡眠图设备
    • 脉搏血氧仪
    • 活动追踪系统
    • 其他
• 市场分析、洞察与预测 - 按最终用户划分
  • 睡眠实验室诊所
  • 家庭医疗保健及其他场所
• 市场分析、洞察与预测 - 按地区划分
  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第六章 北美睡眠呼吸中止设备市场分析、洞察与预测（2021-2034）

• 依国家划分
  • 美国
  • 加拿大

第七章：欧洲睡眠呼吸中止设备市场分析、洞察与预测（2021-2034）

• 依国家划分
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 义大利
  • 斯堪的纳维亚
  • 欧洲其他地区

第八章 亚太地区睡眠呼吸中止设备市场分析、洞察与预测（2021-2034）

• 依国家划分
  • 日本
  • 中国
  • 印度
  • 澳大利亚
  • 东南亚
  • 亚太其他地区

第九章：拉丁美洲睡眠呼吸中止设备市场分析、洞察与预测（2021-2034）

• 依国家划分
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第十章：中东与非洲睡眠呼吸中止症治疗设备市场分析、洞察与预测（2021-2034）

• 依国家划分
  • 海湾合作委员会
  • 南非
  • 其他地区中东和非洲

第十一章 竞争分析

• 全球市占率分析（2025 年）
• 公司简介
  • 皇家飞利浦公司 (Koninklijke Philips N.V.)
  • Openairway
  • Cadwell Industries, Inc.
  • ResMed
  • Fisher & Paykel Healthcare Limited
  • Invacare Corporation
  • SomnoMed
  • Compumedics Limited
  • Braebon Medical Corporation

Growth Factors of sleep apnea devices Market

The global sleep apnea devices market is witnessing substantial growth due to the rising prevalence of sleep-related breathing disorders and increasing awareness regarding early diagnosis and treatment. Sleep apnea is a serious sleep disorder characterized by repeated interruptions in breathing during sleep, leading to reduced oxygen supply to the brain and other organs. This condition is more common among elderly individuals and patients suffering from comorbidities such as obesity, diabetes, hypertension, and cardiovascular disorders. According to Fortune Business Insights, the global sleep apnea devices market size was valued at USD 10.30 billion in 2025. The market is projected to grow from USD 11.00 billion in 2026 to USD 22.87 billion by 2034, exhibiting a CAGR of 9.59% during the forecast period.

North America dominated the global market in 2025, accounting for a 49.55% market share, driven by a high prevalence of obstructive sleep apnea (OSA), favorable reimbursement policies, and strong adoption of technologically advanced sleep apnea devices.

Market Drivers

The primary growth driver for the sleep apnea devices market is the rising prevalence of obstructive sleep apnea worldwide. According to data published by the National Center for Biotechnology Information (NCBI), approximately 936 million people globally suffer from mild to severe OSA, while 425 million people are affected by moderate to severe OSA. Sedentary lifestyles, obesity, poor sleep patterns, and increased stress levels are major contributors to the rising incidence of this condition.

In addition, the growing geriatric population and increasing burden of chronic diseases are leading to higher diagnosis and treatment rates. Awareness initiatives and campaigns by organizations such as the National Sleep Foundation are further encouraging early diagnosis and adoption of sleep apnea devices. The positive impact of COVID-19, which increased stress-related sleep disorders, also supported higher demand for diagnostic and therapeutic devices during and after the pandemic.

Market Trends

A key trend shaping the market is the growing adoption of technologically advanced and patient-friendly devices. Oral appliances such as mandibular advancement devices (MADs) are gaining popularity due to their comfort, portability, and non-invasive nature. In February 2024, the U.S. FDA approved AIO BREATHE, a new mandibular repositioning device, reflecting rising innovation in oral sleep apnea solutions.

Another significant trend is the increasing use of portable and cost-effective diagnostic devices, such as actigraphy systems and home sleep testing tools. These devices are gaining traction due to their affordability and suitability for home-based diagnosis, supporting the shift toward decentralized sleep apnea management.

Market Restraints

Despite strong growth prospects, the market faces challenges related to the high cost of sleep apnea devices. Continuous Positive Airway Pressure (CPAP) machines, which are widely used for OSA treatment, typically cost USD 600 to USD 800 in the U.S., making them expensive for uninsured patients. Limited reimbursement policies and high out-of-pocket expenses in developing countries further restrict device adoption, thereby hampering market growth.

Segmentation Analysis

By Device Type, the market is segmented into therapeutic devices and diagnostic devices. The therapeutic devices segment dominated the market with a 63.36% share in 2026, driven by increasing treatment rates and higher adoption of CPAP devices, oral appliances, and masks. Diagnostic devices are also witnessing growth due to the presence of a large undiagnosed population and increasing awareness regarding sleep disorder diagnosis.

By End User, the market is segmented into homecare & other settings and sleep laboratories & clinics. The homecare & other settings segment dominated with a 53.83% share in 2026, supported by the growing preference for home-based treatment and the launch of portable diagnostic devices. Sleep laboratories and clinics are also expected to grow steadily due to rising patient admissions and availability of skilled sleep technicians.

Regional Insights

North America led the market, with a market size of USD 5.11 billion in 2025, and the U.S. market projected to reach USD 5.10 billion by 2026.

Asia Pacific is expected to register the fastest CAGR, driven by rising prevalence of sleep apnea and increasing awareness. By 2026, Japan is projected to reach USD 0.47 billion, China USD 0.62 billion, and India USD 0.19 billion.

Europe is projected to grow steadily, with the UK market reaching USD 0.47 billion and Germany USD 0.73 billion by 2026, supported by high prevalence among the geriatric population.

Competitive Landscape

The market is highly competitive, with ResMed holding a dominant position due to its strong product portfolio and continuous innovation. Other key players include Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, SomnoMed, Compumedics Limited, and Braebon Medical Corporation. These companies focus on product launches, FDA approvals, and strategic acquisitions to strengthen their market presence.

Conclusion

In conclusion, the global sleep apnea devices market is expected to grow significantly from USD 10.30 billion in 2025 to USD 22.87 billion by 2034, driven by rising prevalence of obstructive sleep apnea, growing awareness, technological advancements, and increasing preference for home-based care. Although high device costs and reimbursement limitations remain key challenges, continuous innovation, expanding diagnostic capabilities, and increasing healthcare investments are expected to sustain robust market growth throughout the forecast period.

Segmentation

By Device Type

• Therapeutic Devices
  • Positive Airway Pressure Devices
  • Continuous Positive Airway Pressure (CPAP) Devices
  • Bilevel Positive Airway Pressure (BPAP) Devices
  • Others
  • Masks and Accessories
  • Others
• Diagnostic Devices
  • Polysomnography Devices
  • Pulse Oximeter
  • Actigraphy Systems
  • Others

By End User

• Sleep Laboratories & Clinics
• Homecare & Other Settings

By Geography

• North America (By Device Type, By End User, and By Country)
  • U.S. (By Device Type)
  • Canada (By Device Type)
• Europe (By Device Type, By End User, and By Country/Sub-region)
  • U.K. (By Device Type)
  • Germany (By Device Type)
  • France (By Device Type)
  • Italy (By Device Type)
  • Spain (By Device Type)
  • Scandinavia (By Device Type)
  • Rest of Europe (By Device Type)
• Asia Pacific (By Device Type, By End User, and By Country/Sub-region)
  • Japan (By Device Type)
  • India (By Device Type)
  • China (By Device Type)
  • Australia (By Device Type)
  • Southeast Asia (By Device Type)
  • Rest of Asia Pacific (By Device Type)
• Latin America (By Device Type, By End User, and By Country/Sub-region)
  • Brazil (By Device Type)
  • Mexico (By Device Type)
  • Rest of Latin America (By Device Type)
• Middle East & Africa (By Device Type, By End User, and By Country/Sub-region)
  • South Africa (By Device Type)
  • GCC (By Device Type)
• Rest of the Middle East & Africa (By Device Type)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Prevalence of Sleep Apnea, By Key Country/ Regions, 2025
• 4.2. Technological Advancements in Sleep Apnea Devices
• 4.3. Key Industry Developments - Mergers, Acquisition, and Partnerships
• 4.4. Impact of COVID-19 on the Market

5. Global Sleep Apnea Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Device Type
  • 5.1.1. Therapeutic Devices
    • 5.1.1.1. Positive Airway Pressure Devices
      • 5.1.1.1.1. Continuous Positive Airway Pressure (CPAP) Devices
      • 5.1.1.1.2. Bilevel Positive Airway Pressure (BPAP) Devices
      • 5.1.1.1.3. Others
    • 5.1.1.2. Masks and Accessories
    • 5.1.1.3. Others
  • 5.1.2. Diagnostic Devices
    • 5.1.2.1. Polysomnography Devices
    • 5.1.2.2. Pulse Oximeter
    • 5.1.2.3. Actigraphy Systems
    • 5.1.2.4. Others
• 5.2. Market Analysis, Insights and Forecast - By End User
  • 5.2.1. Sleep Laboratories & Clinics
  • 5.2.2. Homecare & Other Settings
• 5.3. Market Analysis, Insights and Forecast - By Region
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Latin America
  • 5.3.5. Middle East & Africa

6. North America Sleep Apnea Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Device Type
  • 6.1.1. Therapeutic Devices
    • 6.1.1.1. Positive Airway Pressure Devices
      • 6.1.1.1.1. Continuous Positive Airway Pressure (CPAP) Devices
      • 6.1.1.1.2. Bilevel Positive Airway Pressure (BPAP) Devices
      • 6.1.1.1.3. Others
    • 6.1.1.2. Masks and Accessories
    • 6.1.1.3. Others
  • 6.1.2. Diagnostic Devices
    • 6.1.2.1. Polysomnography Devices
    • 6.1.2.2. Pulse Oximeter
    • 6.1.2.3. Actigraphy Systems
    • 6.1.2.4. Others
• 6.2. Market Analysis, Insights and Forecast - By End User
  • 6.2.1. Sleep Laboratories & Clinics
  • 6.2.2. Homecare & Other Settings
• 6.3. Market Analysis, Insights and Forecast - By Country
  • 6.3.1. U.S.
    • 6.3.1.1. By Device Type
  • 6.3.2. Canada
    • 6.3.2.1. By Device Type

7. Europe Sleep Apnea Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Device Type
  • 7.1.1. Therapeutic Devices
    • 7.1.1.1. Positive Airway Pressure Devices
      • 7.1.1.1.1. Continuous Positive Airway Pressure (CPAP) Devices
      • 7.1.1.1.2. Bilevel Positive Airway Pressure (BPAP) Devices
      • 7.1.1.1.3. Others
    • 7.1.1.2. Masks and Accessories
    • 7.1.1.3. Others
  • 7.1.2. Diagnostic Devices
    • 7.1.2.1. Polysomnography Devices
    • 7.1.2.2. Pulse Oximeter
    • 7.1.2.3. Actigraphy Systems
    • 7.1.2.4. Others
• 7.2. Market Analysis, Insights and Forecast - By End User
  • 7.2.1. Sleep Laboratories & Clinics
  • 7.2.2. Homecare & Other Settings
• 7.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.3.1. U.K.
    • 7.3.1.1. By Device Type
  • 7.3.2. Germany
    • 7.3.2.1. By Device Type
  • 7.3.3. France
    • 7.3.3.1. By Device Type
  • 7.3.4. Spain
    • 7.3.4.1. By Device Type
  • 7.3.5. Italy
    • 7.3.5.1. By Device Type
  • 7.3.6. Scandinavia
    • 7.3.6.1. By Device Type
  • 7.3.7. Rest of Europe
    • 7.3.7.1. By Device Type

8. Asia pacific Sleep Apnea Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Device Type
  • 8.1.1. Therapeutic Devices
    • 8.1.1.1. Positive Airway Pressure Devices
      • 8.1.1.1.1. Continuous Positive Airway Pressure (CPAP) Devices
      • 8.1.1.1.2. Bilevel Positive Airway Pressure (BPAP) Devices
      • 8.1.1.1.3. Others
    • 8.1.1.2. Masks and Accessories
    • 8.1.1.3. Others
  • 8.1.2. Diagnostic Devices
    • 8.1.2.1. Polysomnography Devices
    • 8.1.2.2. Pulse Oximeter
    • 8.1.2.3. Actigraphy Systems
    • 8.1.2.4. Others
• 8.2. Market Analysis, Insights and Forecast - By End User
  • 8.2.1. Sleep Laboratories & Clinics
  • 8.2.2. Homecare & Other Settings
• 8.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.3.1. Japan
    • 8.3.1.1. By Device Type
  • 8.3.2. China
    • 8.3.2.1. By Device Type
  • 8.3.3. India
    • 8.3.3.1. By Device Type
  • 8.3.4. Australia
    • 8.3.4.1. By Device Type
  • 8.3.5. Southeast Asia
    • 8.3.5.1. By Device Type
  • 8.3.6. Rest of Asia Pacific
    • 8.3.6.1. By Device Type

9. Latin America Sleep Apnea Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Device Type
  • 9.1.1. Therapeutic Devices
    • 9.1.1.1. Positive Airway Pressure Devices
      • 9.1.1.1.1. Continuous Positive Airway Pressure (CPAP) Devices
      • 9.1.1.1.2. Bilevel Positive Airway Pressure (BPAP) Devices
      • 9.1.1.1.3. Others
    • 9.1.1.2. Masks and Accessories
    • 9.1.1.3. Others
  • 9.1.2. Diagnostic Devices
    • 9.1.2.1. Polysomnography Devices
    • 9.1.2.2. Pulse Oximeter
    • 9.1.2.3. Actigraphy Systems
    • 9.1.2.4. Others
• 9.2. Market Analysis, Insights and Forecast - By End User
  • 9.2.1. Sleep Laboratories & Clinics
• 9.3. Homecare & Other Settings
• 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.4.1. Brazil
    • 9.4.1.1. By Device Type
  • 9.4.2. Mexico
    • 9.4.2.1. By Device Type
  • 9.4.3. Rest of Latin America
    • 9.4.3.1. By Device Type

10. Middle East & Africa Sleep Apnea Devices Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Device Type
  • 10.1.1. Therapeutic Devices
    • 10.1.1.1. Positive Airway Pressure Devices
      • 10.1.1.1.1. Continuous Positive Airway Pressure (CPAP) Devices
      • 10.1.1.1.2. Bilevel Positive Airway Pressure (BPAP) Devices
      • 10.1.1.1.3. Others
    • 10.1.1.2. Masks and Accessories
    • 10.1.1.3. Others
  • 10.1.2. Diagnostic Devices
    • 10.1.2.1. Polysomnography Devices
    • 10.1.2.2. Pulse Oximeter
    • 10.1.2.3. Actigraphy Systems
    • 10.1.2.4. Others
• 10.2. Market Analysis, Insights and Forecast - By End User
  • 10.2.1. Sleep Laboratories & Clinics
  • 10.2.2. Homecare & Other Settings
• 10.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.3.1. GCC Countries
    • 10.3.1.1. By Device Type
  • 10.3.2. South Africa
    • 10.3.2.1. By Device Type
  • 10.3.3. Rest of Middle East & Africa
    • 10.3.3.1. By Device Type

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Koninklijke Philips N.V.
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Openairway
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Cadwell Industries, Inc.
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. ResMed
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Fisher & Paykel Healthcare Limited
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Invacare Corporation
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. SomnoMed
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Compumedics Limited
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Braebon Medical Corporation
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & Services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)

List of Tables

• Table 1: Global Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 2: Global Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Therapeutic Devices, 2021-2034
• Table 3: Global Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Positive Airway Pressure Devices, 2021-2034
• Table 4: Global Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Diagnostic Devices, 2021-2034
• Table 5: Global Sleep Apnea Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
• Table 6: Global Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Region, 2021-2034
• Table 7: North America Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 8: North America Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Therapeutic Devices, 2021-2034
• Table 9: North America Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Positive Airway Pressure Devices, 2021-2034
• Table 10: North America Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Diagnostic Devices, 2021-2034
• Table 11: North America Sleep Apnea Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
• Table 12: North America Sleep Apnea Devices Market Revenue (USD billion) Forecast, By Country, 2021-2034
• Table 13: U.S. Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 14: Canada Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 15: Europe Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 16: Europe Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Therapeutic Devices, 2021-2034
• Table 17: Europe Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Positive Airway Pressure Devices, 2021-2034
• Table 18: Europe Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Diagnostic Devices, 2021-2034
• Table 19: Europe Sleep Apnea Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
• Table 20: Europe Sleep Apnea Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
• Table 21: U.K. Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 22: Germany Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 23: France Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 24: Spain Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 25: Italy Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 26: Scandinavia Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 27: Rest of Europe Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 28: Asia Pacific Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 29: Asia Pacific Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Therapeutic Devices, 2021-2034
• Table 30: Asia Pacific Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Positive Airway Pressure Devices, 2021-2034
• Table 31: Asia Pacific Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Diagnostic Devices, 2021-2034
• Table 32: Asia Pacific Sleep Apnea Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
• Table 33: Asia Pacific Sleep Apnea Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
• Table 34: Japan Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 35: China Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 36: India Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 37: Australia Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 38: Southeast Asia Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 39: Rest of Asia Pacific Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 40: Latin America Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 41: Latin America Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Therapeutic Devices, 2021-2034
• Table 42: Latin America Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Positive Airway Pressure Devices, 2021-2034
• Table 43: Latin America Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Diagnostic Devices, 2021-2034
• Table 44: Latin America Sleep Apnea Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
• Table 45: Latin America Sleep Apnea Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
• Table 46: Brazil Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 47: Mexico Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 48: Rest of Latin America Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 49: Middle East & Africa Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 50: Middle East & Africa Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Therapeutic Devices, 2021-2034
• Table 51: Middle East & Africa Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Positive Airway Pressure Devices, 2021-2034
• Table 52: Middle East & Africa Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Diagnostic Devices, 2021-2034
• Table 53: Middle East & Africa Sleep Apnea Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
• Table 54: Middle East & Africa Sleep Apnea Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
• Table 55: GCC Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 56: South Africa Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
• Table 57: Rest of Middle East & Africa Sleep Apnea Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034

List of Figures

• Figure 1: Global Sleep Apnea Devices Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
• Figure 2: Global Sleep Apnea Devices Market Value Share (%), by Device Type, 2025 & 2034
• Figure 3: Global Sleep Apnea Devices Market Value Share (%), by End User, 2025 & 2034
• Figure 4: Global Sleep Apnea Devices Market Value (USD billion), by Region, 2025 & 2034
• Figure 5: North America Sleep Apnea Devices Market Value (USD billion), by Device Type, 2025 & 2034
• Figure 6: North America Sleep Apnea Devices Market Value Share (%), by Device Type, 2025
• Figure 7: North America Sleep Apnea Devices Market Value (USD billion), by End User, 2025 & 2034
• Figure 8: North America Sleep Apnea Devices Market Value Share (%), by End User, 2025
• Figure 9: North America Sleep Apnea Devices Market Value (USD billion), By Country, 2025 & 2034
• Figure 10: North America Sleep Apnea Devices Market Value Share (%), By Country, 2025
• Figure 11: Europe Sleep Apnea Devices Market Value (USD billion), by Device Type, 2025 & 2034
• Figure 12: Europe Sleep Apnea Devices Market Value Share (%), by Device Type, 2025
• Figure 13: Europe Sleep Apnea Devices Market Value (USD billion), by End User, 2025 & 2034
• Figure 14: Europe Sleep Apnea Devices Market Value Share (%), by End User, 2025
• Figure 15: Europe Sleep Apnea Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
• Figure 16: Europe Sleep Apnea Devices Market Value Share (%), By Country/ Sub-region, 2025
• Figure 17: Asia Pacific Sleep Apnea Devices Market Value (USD billion), by Device Type, 2025 & 2034
• Figure 18: Asia Pacific Sleep Apnea Devices Market Value Share (%), by Device Type, 2025
• Figure 19: Asia Pacific Sleep Apnea Devices Market Value (USD billion), by End User, 2025 & 2034
• Figure 20: Asia Pacific Sleep Apnea Devices Market Value Share (%), by End User, 2025
• Figure 21: Asia Pacific Sleep Apnea Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
• Figure 22: Asia Pacific Sleep Apnea Devices Market Value Share (%), By Country/ Sub-region, 2025
• Figure 23: Latin America Sleep Apnea Devices Market Value (USD billion), by Device Type, 2025 & 2034
• Figure 24: Latin America Sleep Apnea Devices Market Value Share (%), by Device Type, 2025
• Figure 25: Latin America Sleep Apnea Devices Market Value (USD billion), by End User, 2025 & 2034
• Figure 26: Latin America Sleep Apnea Devices Market Value Share (%), by End User, 2025
• Figure 27: Latin America Sleep Apnea Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
• Figure 28: Latin America Sleep Apnea Devices Market Value Share (%), By Country/ Sub-region, 2025
• Figure 29: Middle East & Africa Sleep Apnea Devices Market Value (USD billion), by Device Type, 2025 & 2034
• Figure 30: Middle East & Africa Sleep Apnea Devices Market Value Share (%), by Device Type, 2025
• Figure 31: Middle East & Africa Sleep Apnea Devices Market Value (USD billion), by End User, 2025 & 2034
• Figure 32: Middle East & Africa Sleep Apnea Devices Market Value Share (%), by End User, 2025
• Figure 33: Middle East & Africa Sleep Apnea Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
• Figure 34: Middle East & Africa Sleep Apnea Devices Market Value Share (%), By Country/ Sub-region, 2025
• Figure 35: Global Sleep Apnea Devices Market Share (%), By Company, 2025